Dr. Dorinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Meadowmont Village Circle
#203
Chapel Hill, NC 27517Phone+1 984-974-5703- Is this information wrong?
Summary
- Dr. Paul Dorinsky is a pulmonologist in Chapel Hill, NC. He received his medical degree from The Ohio State University College of Medicine and has been in practice 39 years. He specializes in a asthma and COPD
Education & Training
Ohio State University HospitalResidency, Internal Medicine, 1979 - 1981- Ohio State University HospitalInternship, Internal Medicine, 1978 - 1979
- Ohio State University College of MedicineClass of 1978
Certifications & Licensure
NC State Medical License 2023 - 2024
PA State Medical License 2009 - 2012
CT State Medical License 1998 - 1999
OH State Medical License 1980 - 1998- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects Start of enrollment: 2017 Apr 17
- Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler® Start of enrollment: 2016 Aug 09
- A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 Start of enrollment: 2017 Oct 17
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsPredictive modeling of COPD exacerbation rates using baseline risk factors.Dave Singh, John R Hurst, Fernando J Martinez, Klaus F Rabe, Mona Bafadhel, Martin Jenkins, Domingo Salazar, Paul Dorinsky, Patrick Darken> ;Therapeutic Advances in Respiratory Disease. 2022 Jul 11
- 2 citationsRelationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related...Dave Singh, Klaus F Rabe, Fernando J Martinez, Matthias Krüll, Martin Jenkins, Mehul Patel, Paul Dorinsky> ;Respiratory Medicine. 2022 Jun 1
- 3 citationsBenefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges:...Mona Bafadhel, Klaus F Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul Patel, Paul Dorinsky> ;International Journal of Chronic Obstructive Pulmonary Disease. 2022 Jan 1
- Join now to see all
Authored Content
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPDJune 2020
Grant Support
- Pathogenesis Of Nonpulmonary Organ Failure In ARDSNational Heart, Lung, And Blood Institute1991–1995
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
